Ni, Xiaomin https://orcid.org/0000-0002-7769-8297
Richardson, R. Blake
Godoy, Andre Schutzer https://orcid.org/0000-0002-0613-9164
Ferla, Matteo P.
Kikawa, Caroline
Scheen, Jenke
Hannon, William W.
Capkin, Eda
Lahav, Noa
Balcomb, Blake H.
Marples, Peter G. https://orcid.org/0000-0002-8787-7969
Fairhead, Michael
Wang, SiYi
Williams, Eleanor P. https://orcid.org/0000-0002-1331-9518
Tomlinson, Charles W. E. https://orcid.org/0000-0002-1845-6028
Aschenbrenner, Jasmin C. https://orcid.org/0000-0002-4318-0481
Lithgo, Ryan M.
Winokan, Max
Giroud, Charline
Dolci, Isabela https://orcid.org/0000-0002-2431-0383
Fernandes, Rafaela Sachetto
Oliva, Glaucius https://orcid.org/0000-0003-2719-0302
Chandran, Anu V.
Xavier, Mary-Ann
Walsh, Martin A. https://orcid.org/0000-0001-5683-1151
Thompson, Warren https://orcid.org/0000-0003-1474-7810
Bloom, Jesse D. https://orcid.org/0000-0003-1267-3408
Kenton, Nathaniel T.
Lee, Alpha A.
von Delft, Annette
Barr, Haim
Kirkegaard, Karla https://orcid.org/0000-0001-7628-3770
Koekemoer, Lizbé https://orcid.org/0000-0001-9226-9127
Fearon, Daren https://orcid.org/0000-0003-3529-7863
Evans, Matthew J. https://orcid.org/0000-0002-4991-3877
von Delft, Frank https://orcid.org/0000-0003-0378-0017
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI171399)
Article History
Received: 21 January 2025
Accepted: 25 August 2025
First Online: 8 October 2025
Competing interests
: A.S.G consults for DNDi and MMV. A.A.L. is a shareholder and employee of PostEra, which has commercial interests in the discovery, development and commercialization of therapeutics. Other authors declare no competing interests.